ACEI or ARB Therapy for Left Ventricular Systolic Dysfunction-HF Patients
Percent of HF patients with LVSD who are prescribed an ACEI or ARB at hospital discharge. For purposes of this measure, LVSD is defined as chart documentation of a LVEF less than 40% or a narrative description of left ventricular systolic function consistent with moderate or severe systolic dysfunction.
ACP supports this measure. The balance of evidence shows that long-term treatment with beta blockers and angiotensin converting enzyme inhibitors can lessen the symptoms of heart failure, improve the clinical status of patients and enhance the patient's overall sense of well-being. The measure aligns with current guidelines and represents high-value care.